Generation of human otic neuronal organoids using pluripotent stem cells
Cell Proliferation · 2023
DOI: 10.1111/cpr.13434 ↗At a glance
Journal article in Cell Proliferation, 2023. Written by Gaoying Sun and 7 co-authors. Institution: State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China. Major MEDLINE topics: Pluripotent Stem Cells, Hearing Loss, Sensorineural. Cited 10 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China, Strategic Priority Research Program of CAS.
Abstract (original language)
Otic neurons, also known as spiral ganglion neurons (SGNs) in mammalian cochlea, transmit electrical signals from sensory hair cells to cochlear nuclei of the auditory system. SGNs are sensitive to toxic insults, vulnerable to get irreversible damaged and hardly regenerate after damage, causing persistent sensorineural hearing loss. Yet, to get authentic SGNs for research or therapeutic purpose remains challenging. Here we developed a protocol to generate human otic neuronal organoids (hONOs) from human pluripotent stem cells (hESCs), in which hESCs were step‐wisely induced to SGNs of the corresponding stages according to their developmental trajectory. The hONOs were enriched for SGN‐like cells at early stage, and for both neurons and astrocytes, Schwann cells or supporting cells thereafter. In these hONOs, we also determined the existence of typical Type I and Type II SGNs. Mature hONOs (at differentiation Day 60) formed neural network, featured by giant depolarizing potential (GDP)‐like events and rosette‐organized regions‐elicited calcium traces. Electrophysiological analysis confirmed the existence of glutamate‐responsive neurons in these hONOs. The otic neuronal organoids generated in this study provide an ideal model to study SGNs and related disorders, facilitating therapeutic development for sensorineural hearing loss.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
- University of Chinese Academy of Sciences, Beijing, China.
- Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.
- Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China.
- National Stem Cell Resource Center, Chinese Academy of Sciences, Beijing, China.
ORCID profiles: Baoyang Hu
Funding
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Strategic Priority Research Program of CAS
Cite
APA
Sun, G., Tang, M., Wang, X., Li, D., Liu, W., Qi, J., Wang, H., & Hu, B. (2023). Generation of human otic neuronal organoids using pluripotent stem cells. Cell Proliferation. https://doi.org/10.1111/cpr.13434
Vancouver
Sun G, Tang M, Wang X, Li D, Liu W, Qi J, et al. Generation of human otic neuronal organoids using pluripotent stem cells. Cell Proliferation. 2023. doi:10.1111/cpr.13434
BibTeX
@article{Sun2023,
author = {Sun, Gaoying and Tang, Mingming and Wang, Xinyue and Li, Da and Liu, Wenwen and Qi, Jianhuan and Wang, Haibo and Hu, Baoyang},
title = {Generation of human otic neuronal organoids using pluripotent stem cells},
journal = {Cell Proliferation},
year = {2023},
doi = {10.1111/cpr.13434}
}
EUVIMED